FSCN1 and neoplasm: Li et al. reported that activation of the CREB signaling pathway upregulates FSCN1 expression in breast adenocarcinoma, head and neck squamous cell carcinoma, and lung adenocarcinoma cells, leading to enhanced cancer cell invasion in vitro and tumor metastasis in vivo120.